Logrippo, G.A. : Investigations of the use of beta-propiolactone in virus inactivation. Ann. N. Y. Acad. Sci., 83: 578, 1960.
2.
Murray, R.: National Institutes of Health, Public Health Service, Bethesda, Md., Personal communication.
3.
Murray, R., Diefenbach, C.L., Geller, H., Leon, N.C., AND Ratner, F.: The problems of reducing the danger of serum hepatitis from blood and blood products. New York State J. Med., 55: 1145, 1955 .
4.
Logrippo, G.A., AND Rupe, C.E.: Chemical sterilization of whole blood and plasma: beta-propiolactone . In Henry Ford Hospital Symposium: Hepatitis Frontiers, Ch. 31. Little, Brown & Company, Boston, 1957.
5.
Hartman, F.W., AND Logrippo, G.A.: Combined beta-propiolactone and ultraviolet irradiation for plasma sterilization . In Henry Ford Hospital Symposium: Hepatitis Frontiers, Ch. 33. Little, Brown & Company, Boston, 1957.
6.
Kelly, A.R., Hartman, F.W., AND Rupe, C.E.: The toxicology of beta-propiolactone. In Henry Ford Hospital Symposium: Hepatitis Frontiers, Ch. 32. Little, Brown & Company, Boston, 1957 .
7.
Walpole, A., Roberts, D.C., Rose, F.L., Hendry, J.A., AND Homer, R.F.: Cytotoxic agents. IV. The carcinogenic action of some monofunctional ethyleneimine derivatives. Brit. J. Pharmacol., 9: 306, 1954.
8.
Roe, F.J.C., AND Salaman, M.H.: Further studies on incomplete carcinogenesis: Triethelene melamine, 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumor formation in the mouse . Brit. J. Cancer, 9: 177, 1955.
9.
Roe, F.J.C., AND Glendenning, D.M. : The carcinogenicity of beta-propiolactone for mouse skin. Brit. J. Cancer, 10: 357, 1956.
10.
Monto, R.W. : New approach to the thrombocytopathies (thrombocytopathy A). Fed. Proc., 17: 396, 1958.
11.
Johnson, S.A. , AND Basinski, D.H.: Platelet factor 3 in blood coagulation . Fed. Proc., 17: 81, 1958.
12.
Logrippo, G.A. : Sterilization of platelet factor-3 with beta-propiolactone and ultraviolet irradiation. Fed. Proc., 17: 524, 1958.
13.
Logrippo, G.A. , Overhulse, P.R., Szilagyi , D.E., AND Hartman, F.W.: Procedure for sterilization of arterial homografts with beta-propiolactone. Lab. Invest., 4: 217, 1955.
14.
Szilagyi, D.E. , Mcdonald, R.T., Smith , R.F., AND Whitcomb , J.G.: Biological fate of human arterial homografts. A. M. A. Arch. Surg., 75: 506, 1957.
15.
Logrippo, G.A. , Burgress, B., Teodora , R., AND Fleming, F.L.: Procedure for bone sterilization with beta-propiolactone . J. Bone & Joint Surg., 39: 1356, 1957 .
16.
Logrippo, G.A. , AND Eidam, C.R.: Sterilization and detoxification of serum for tissue culture by combined beta-propiolactone and ultraviolet irradiation . 9th Annual Meeting, Tissue Culture Association , Philadelphia, 1958.
17.
Logrippo, G.A. : The hazards in the use of serum for tissue culture media. Univ. Michigan M. Bull., 24: 191, 1958.